Article info
PDFHepatology
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication
- Correspondence to Dr E Hildt, University of Kiel-UKSH, Institute of Infection Medicine, Molecular Medical Virology, Brunswiker Strasse. 4, D-24105 Kiel, Germany; hildt{at}infmed.uni-kiel.de
Citation
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication
Publication history
- Revised July 12, 2009
- Accepted July 21, 2009
- First published August 25, 2009.
Online issue publication
May 20, 2016
Article Versions
- Previous version (20 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and British Society of Gastroenterology. All rights reserved.